These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. [Effect of glucose on the antibiotic activity and antibiotic resistance of Streptomyces peucetius subsp. caesius ATCC 27952-2 and its mutants]. Dubitskaia LP; Fedorenko VA Antibiot Khimioter; 2002; 47(6):7-11. PubMed ID: 12422641 [TBL] [Abstract][Full Text] [Related]
14. Implication of orphan histidine kinase (OhkAsp) in biosynthesis of doxorubicin and daunorubicin in Streptomyces peucetius ATCC 27952. Pokhrel AR; Nguyen HT; Dhakal D; Chaudhary AK; Sohng JK Microbiol Res; 2018 Sep; 214():37-46. PubMed ID: 30031480 [TBL] [Abstract][Full Text] [Related]
15. Doxorubicin overproduction in Streptomyces peucetius: cloning and characterization of the dnrU ketoreductase and dnrV genes and the doxA cytochrome P-450 hydroxylase gene. Lomovskaya N; Otten SL; Doi-Katayama Y; Fonstein L; Liu XC; Takatsu T; Inventi-Solari A; Filippini S; Torti F; Colombo AL; Hutchinson CR J Bacteriol; 1999 Jan; 181(1):305-18. PubMed ID: 9864344 [TBL] [Abstract][Full Text] [Related]
16. A bacterial analog of the mdr gene of mammalian tumor cells is present in Streptomyces peucetius, the producer of daunorubicin and doxorubicin. Guilfoile PG; Hutchinson CR Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8553-7. PubMed ID: 1924314 [TBL] [Abstract][Full Text] [Related]
17. Proteomic approach to enhance doxorubicin production in panK-integrated Streptomyces peucetius ATCC 27952. Song E; Malla S; Yang YH; Lee K; Kim EJ; Lee HC; Sohng JK; Oh MK; Kim BG J Ind Microbiol Biotechnol; 2011 Sep; 38(9):1245-53. PubMed ID: 21308395 [TBL] [Abstract][Full Text] [Related]
18. Complete genome sequence of Streptomyces peucetius ATCC 27952, the producer of anticancer anthracyclines and diverse secondary metabolites. Dhakal D; Lim SK; Kim DH; Kim BG; Yamaguchi T; Sohng JK J Biotechnol; 2018 Feb; 267():50-54. PubMed ID: 29307836 [TBL] [Abstract][Full Text] [Related]
19. Production of the antitumor drug epirubicin (4'-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius. Madduri K; Kennedy J; Rivola G; Inventi-Solari A; Filippini S; Zanuso G; Colombo AL; Gewain KM; Occi JL; MacNeil DJ; Hutchinson CR Nat Biotechnol; 1998 Jan; 16(1):69-74. PubMed ID: 9447597 [TBL] [Abstract][Full Text] [Related]
20. Self-resistance mechanism in Streptomyces peucetius: overexpression of drrA, drrB and drrC for doxorubicin enhancement. Malla S; Niraula NP; Liou K; Sohng JK Microbiol Res; 2010 May; 165(4):259-67. PubMed ID: 19651502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]